Clinical Discussion of TAFLINAR (dabrafenib)* will be presented by David Minor, MD., Associate Director, California Pacific Center for Melanoma Research and Treatment.
This event is open to invited guests only.
*This is a non-CME, non-promotional scientific program sponsored by GSK Oncology.